An Overview of Bernard–Soulier Syndrome – ICHCC
Iranian Comprehensive Hemophilia Care Center (ICHCC) shared a post on LinkedIn:
“Bernard–Soulier Syndrome (BSS)
When platelets are present, but don’t function properly!
Bernard–Soulier Syndrome (BSS) is a rare inherited platelet disorder caused by a defect in the GPIb-IX-V receptor complex on the platelet surface.
What is the role of this receptor?
The GPIb receptor binds to von Willebrand factor (vWF) and mediates the initial adhesion of platelets to injured blood vessels.
In BSS, this critical first step of primary hemostasis is impaired, resulting in a bleeding tendency.
Clinical Features:
- Easy bruising
- Recurrent epistaxis
- Gingival bleeding
- Menorrhagia in adolescent girls and women
- Prolonged bleeding after surgery or dental procedures
Typical Laboratory Findings:
- Mild to moderate thrombocytopenia
- Giant platelets on peripheral blood smear
- Prolonged bleeding time (or abnormal platelet function testing)
- Normal PT and aPTT
Key Examination Point:
On platelet aggregation studies: Reduced or absent response to ristocetin.
However: The abnormality is not corrected by adding normal plasma, helping differentiate BSS from von Willebrand disease.
Genetics: Most cases are inherited in an autosomal recessive pattern and are more common in populations with consanguineous marriages.
Management:
- Bleeding prevention and patient education
- Avoidance of aspirin and NSAIDs
- Tranexamic acid for mucosal bleeding
- Platelet transfusion for major bleeding episodes or surgical procedures
Clinical Pearl:
A patient with mucocutaneous bleeding, giant platelets, thrombocytopenia, and an abnormal ristocetin response should raise strong suspicion for Bernard–Soulier Syndrome.
Take-Home Message:
Bernard–Soulier Syndrome – Big Platelets plus Bleeding plus Defective Ristocetin Response.”
Other posts featuring ICHCC on Hemostasis Today.
-
Sep 20, 2026, 16:26Thomas Schinecker: A New Era for Health Innovation – Inside the Roche Genentech Innovation Center
-
Sep 20, 2026, 16:19Astha Srivastava: The Missing Megakaryocytes in Amegakaryocytic Thrombocytopenia
-
Sep 20, 2026, 16:19Heghine Khachatryan: An Elegant Example of Precision Thrombolysis – Targeting the Scaffold of Microvascular Thrombosis
-
Sep 20, 2026, 16:01Mohamed Ismail: Managing Extensive Iliofemoral and Inferior Vena Cava DVT
-
Sep 20, 2026, 15:58Can αIIbβ3 Receptor Play a Role in Platelet Production – Glanzmann’s Research Foundation
-
Sep 20, 2026, 15:46Alexsander Santiago: Evaluating Clinical Harm from Missing versus Overdiagnosing HIT
-
Sep 20, 2026, 15:28Nico Gagelmann: iMTSS to Dissect the Drivers of Post-Transplant Outcomes
-
Sep 20, 2026, 15:10Ashenafi Tazebew Amare: Building the Future of Blood and Specialized Healthcare
-
Sep 20, 2026, 15:03Bastu Odoka: How Much Does Blood Transfusion Raise Hemoglobin in Children?